ProstaLund AB (PLUN) - Net Assets

Latest as of June 2025: Skr44.54 Million SEK ≈ $4.79 Million USD

Based on the latest financial reports, ProstaLund AB (PLUN) has net assets worth Skr44.54 Million SEK (≈ $4.79 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr55.84 Million ≈ $6.01 Million USD) and total liabilities (Skr11.30 Million ≈ $1.22 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read ProstaLund AB (PLUN) financial obligations for a breakdown of total debt and financial obligations.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Skr44.54 Million
% of Total Assets	79.76%
Annual Growth Rate	22.8%
5-Year Change	117.66%
10-Year Change	137.92%
Growth Volatility	46.65

ProstaLund AB - Net Assets Trend (2012–2024)

This chart illustrates how ProstaLund AB's net assets have evolved over time, based on quarterly financial data. Also explore PLUN total assets for the complete picture of this company's asset base.

Annual Net Assets for ProstaLund AB (2012–2024)

The table below shows the annual net assets of ProstaLund AB from 2012 to 2024. For live valuation and market cap data, see ProstaLund AB stock valuation.

Year	Net Assets	Change
2024-12-31	Skr55.18 Million ≈ $5.94 Million	-0.20%
2023-12-31	Skr55.29 Million ≈ $5.95 Million	+32.64%
2022-12-31	Skr41.69 Million ≈ $4.49 Million	+17.57%
2021-12-31	Skr35.46 Million ≈ $3.82 Million	+39.85%
2020-12-31	Skr25.35 Million ≈ $2.73 Million	+14.03%
2019-12-31	Skr22.23 Million ≈ $2.39 Million	+74.90%
2018-12-31	Skr12.71 Million ≈ $1.37 Million	-7.72%
2017-12-31	Skr13.78 Million ≈ $1.48 Million	-55.29%
2016-12-31	Skr30.81 Million ≈ $3.32 Million	+32.85%
2015-12-31	Skr23.19 Million ≈ $2.50 Million	+95.13%
2014-12-31	Skr11.89 Million ≈ $1.28 Million	+127.09%
2013-12-31	Skr5.23 Million ≈ $563.26K	+11.58%
2012-12-31	Skr4.69 Million ≈ $504.83K	--

Equity Component Analysis

This analysis shows how different components contribute to ProstaLund AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 3562300000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Common Stock	Skr14.50 Million	26.27%
Other Comprehensive Income	Skr32.25 Million	58.45%
Other Components	Skr44.62 Million	80.85%
Total Equity	Skr55.18 Million	100.00%

ProstaLund AB Competitors by Market Cap

The table below lists competitors of ProstaLund AB ranked by their market capitalization.

Company	Market Cap
Kollect on Demand Holding Ab ST:KOLL	$719.15K
M.T.I Wireless Edge Ltd LSE:MWE	$723.64K
ARC MINERALS LTD F:DFYA	$724.05K
IMAGE POWER S.A. ZY -10 F:7UQ	$724.14K
Upgrade Invest Nordic AB ST:UPGRAD	$715.69K
Glen Eagle Resources Inc V:GER	$715.41K
CERo Therapeutics Holdings, Inc. Common Stock NASDAQ:CERO	$715.38K
Founder Group Limited Ordinary Shares NASDAQ:FGL	$714.45K

Equity Growth Attribution

This analysis shows how different factors contributed to changes in ProstaLund AB's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 55,291,000 to 55,181,000, a change of -110,000 (-0.2%).
Net loss of 22,631,000 reduced equity.
New share issuances of 26,952,000 increased equity.
Other comprehensive income increased equity by 33,395,999.
Other factors decreased equity by 37,826,999.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	Skr-22.63 Million	-41.01%
Share Issuances	Skr26.95 Million	+48.84%
Other Comprehensive Income	Skr33.40 Million	+60.52%
Other Changes	Skr-37.83 Million	-68.55%
Total Change	Skr-	-0.20%

Book Value vs Market Value Analysis

This analysis compares ProstaLund AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.16x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2012-12-31	Skr0.89	Skr0.21	x
2013-12-31	Skr0.99	Skr0.21	x
2014-12-31	Skr1.62	Skr0.21	x
2015-12-31	Skr2.55	Skr0.21	x
2016-12-31	Skr2.42	Skr0.21	x
2017-12-31	Skr1.08	Skr0.21	x
2018-12-31	Skr0.90	Skr0.21	x
2019-12-31	Skr0.89	Skr0.21	x
2020-12-31	Skr0.66	Skr0.21	x
2021-12-31	Skr0.74	Skr0.21	x
2022-12-31	Skr0.77	Skr0.21	x
2023-12-31	Skr0.81	Skr0.21	x
2024-12-31	Skr1.38	Skr0.21	x

Capital Efficiency Dashboard

This dashboard shows how efficiently ProstaLund AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -41.01%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -164.89%
• Asset Turnover: 0.22x
• Equity Multiplier: 1.12x
Recent ROE (-41.01%) is above the historical average (-52.24%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2012	-11.96%	-7.33%	1.11x	1.47x	Skr-1.03 Million
2013	-88.75%	-53.92%	0.90x	1.84x	Skr-5.17 Million
2014	-65.51%	-80.99%	0.61x	1.33x	Skr-8.97 Million
2015	-40.41%	-68.85%	0.50x	1.17x	Skr-11.69 Million
2016	-38.86%	-81.95%	0.41x	1.14x	Skr-15.06 Million
2017	-122.65%	-124.73%	0.76x	1.30x	Skr-18.27 Million
2018	-101.88%	-95.45%	0.71x	1.51x	Skr-14.22 Million
2019	-48.25%	-83.25%	0.49x	1.19x	Skr-12.95 Million
2020	-39.61%	-80.55%	0.40x	1.22x	Skr-12.58 Million
2021	-22.33%	-46.38%	0.39x	1.23x	Skr-11.46 Million
2022	-27.11%	-64.92%	0.34x	1.22x	Skr-15.47 Million
2023	-30.76%	-76.60%	0.34x	1.18x	Skr-22.54 Million
2024	-41.01%	-164.89%	0.22x	1.12x	Skr-28.15 Million

Industry Comparison

This section compares ProstaLund AB's net assets metrics with peer companies in the Medical Care Facilities industry.

Industry Context

Industry: Medical Care Facilities
Average net assets among peers: $3,176,387,250
Average return on equity (ROE) among peers: 6.80%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
ProstaLund AB (PLUN)	Skr44.54 Million	-11.96%	0.25x	$716.78K
Ambea AB (AMBEA)	$4.99 Billion	12.43%	2.71x	$1.24 Billion
Attendo AB (publ) (ATT)	$4.96 Billion	1.13%	3.25x	$1.66 Billion
Humana AB (publ) (HUM)	$2.74 Billion	7.67%	2.58x	$252.31 Million
Medicover AB (publ) (MCOV-B)	$23.55 Million	5.95%	0.72x	$1.66 Billion

About ProstaLund AB

ST:PLUN Sweden Medical Care Facilities

Market Cap

$716.78K

Skr6.66 Million SEK

Market Cap Rank

#30394 Global

#717 in Sweden

Share Price

Skr0.21

Change (1 day)

-35.15%

52-Week Range

Skr0.21 - Skr7.45

All Time High

Skr15.54